Is antisense oligonucleotides targeting K-ras point mutation a promise in the pancreatic cancer treatment in Syrian golden hamsters in vitro and in vivo?

Is antisense oligonucleotides targeting K-ras point mutation a promise in the pancreatic cancer treatment in Syrian golden hamsters in vitro and in vivo? (2004)

Authors:
USP affiliated authors: MACHADO, MARCEL CERQUEIRA CESAR - FM ; BACCHELLA, TELESFORO - FM
Unidade: FM
Subjects: NEOPLASIAS PANCREÁTICAS (TERAPIA); PROGNÓSTICO; FARMACOTERAPIA; METASTASE; INCIDÊNCIA
Language: Inglês
Imprenta:
- Publisher place: Basel
- Date published: 2004
Source:
- Título do periódico: Pancreatology
- ISSN: 1424-3903
- Volume/Número/Paginação/Ano: v. 4, n. 3-4, p. 330, res. P1-10-5, 2004
Conference titles: Joint Meeting of the International Association of Pancreatology (IAP)

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

ABNT

MORIOKA, C. Y et al. Is antisense oligonucleotides targeting K-ras point mutation a promise in the pancreatic cancer treatment in Syrian golden hamsters in vitro and in vivo?. Pancreatology. Basel: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 25 jul. 2024. , 2004
APA

Morioka, C. Y., Machado, M. C. C., Saito, S., Yamago, G. I., Nakada, Y., Godoy, R. S. de, et al. (2004). Is antisense oligonucleotides targeting K-ras point mutation a promise in the pancreatic cancer treatment in Syrian golden hamsters in vitro and in vivo? Pancreatology. Basel: Faculdade de Medicina, Universidade de São Paulo.
NLM

Morioka CY, Machado MCC, Saito S, Yamago GI, Nakada Y, Godoy RS de, Matheus AS, Jukemura J, Bacchella T, Filho DP, Watanabe A. Is antisense oligonucleotides targeting K-ras point mutation a promise in the pancreatic cancer treatment in Syrian golden hamsters in vitro and in vivo? Pancreatology. 2004 ; 4( 3-4): 330.[citado 2024 jul. 25 ]
Vancouver

Morioka CY, Machado MCC, Saito S, Yamago GI, Nakada Y, Godoy RS de, Matheus AS, Jukemura J, Bacchella T, Filho DP, Watanabe A. Is antisense oligonucleotides targeting K-ras point mutation a promise in the pancreatic cancer treatment in Syrian golden hamsters in vitro and in vivo? Pancreatology. 2004 ; 4( 3-4): 330.[citado 2024 jul. 25 ]